Cargando…
Current and emerging management options for patients with Morquio A syndrome
Morquio A syndrome is a lysosomal storage disease associated with mucopolysaccharidosis. It is caused by a deficiency of the lysosomal enzyme, N-acetylgalactosamine-6-sulfate sulfatase, which leads to accumulation of keratan sulfate and condroitin-6 sulfate in multiple organs. Patients present with...
Autores principales: | Algahim, Mohamed F, Almassi, G Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572824/ https://www.ncbi.nlm.nih.gov/pubmed/23413237 http://dx.doi.org/10.2147/TCRM.S24771 |
Ejemplares similares
-
Orthopedic management of the extremities in patients with Morquio A syndrome
por: White, Klane K., et al.
Publicado: (2014) -
International Guidelines for the Management and Treatment of Morquio A Syndrome
por: Hendriksz, Christian J, et al.
Publicado: (2015) -
Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management
por: Solanki, Guirish A., et al.
Publicado: (2013) -
Morquio Syndrome: A Case Report
por: Ramphul, Kamleshun, et al.
Publicado: (2018) -
Voice alterations in patients with Morquio A syndrome
por: Szklanny, Krzysztof, et al.
Publicado: (2017)